Methylglyoxl and osteoprotegerin down-regulation in patients with uncontrolled diabetes mellitus: A possible therapeutic approach to diminish lower extremity amputations
Clinical medicine applied in public health
Discuss the possibility of new targets of pharmaceutical development that may lead to better prognoses in patients with diabetes mellitus. Describe current research elucidating previously unknown immunological connections between aberrant glucose regulation and peripheral vascular disease.
Keywords: Diabetes, Chronic Diseases
Qualified on the content I am responsible for because: I have been the principle investigator of previous research at the graduate level for Harvard University that focused on novel approaches to chronic disease management, specifically for diabetes mellitus. Additionally, I have served on a RIE board for Harvard Vanguard Medical Associates focusing on the efficacy of the roster review process. I also hold a strong interest in the underlying aberrant immune functions that are present in chronic diseases such as diabetes mellitus.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.